Review
Open access
Aug 2026
AR-V7-Driven Mitochondrial Metabolic Reprogramming in Enzalutamide-Resistant Prostate Cancer: Mechanisms and Therapeutic Implications
In conclusion, AR-V7-driven mitochondrial metabolic remodeling is central to enzalutamide resistance; future studies should dissect AR-V7–mitochondria regulatory nodes and optimize mitochondria-targeted combination strategies.
Rong-Xin Chang, Zhuang-Zhuang Zhang
· Serican Journal of Medicine · 0 citations